Variant report

Variant	esv3391909
Chromosome Location	chr19:41632754-41688263
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:1483)
CpG islands
(count:1038)
Chromatin interactive
region (count:13)
LncRNA
region (count:1)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:1483 , 50 per page) page: 1 2 3 4 5 6 7 ... 30

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr19:41650417-41650577	K562	blood:	n/a	n/a
2	ARID3A	chr19:41682096-41682591	HepG2	liver:	n/a	n/a
3	ARID3A	chr19:41664953-41665409	HepG2	liver:	n/a	n/a
4	ARID3A	chr19:41672807-41673485	HepG2	liver:	n/a	n/a
5	ATF1	chr19:41665949-41666184	K562	blood:	n/a	n/a
6	ATF1	chr19:41650377-41650629	K562	blood:	n/a	n/a
7	ATF2	chr19:41632705-41633050	H1-hESC	embryonic stem cell:	n/a	n/a
8	ATF2	chr19:41650238-41650641	H1-hESC	embryonic stem cell:	n/a	n/a
9	ATF3	chr19:41681806-41682604	A549	lung:	n/a	n/a
10	BACH1	chr19:41650392-41650566	K562	blood:	n/a	n/a
11	BACH1	chr19:41633739-41634068	H1-hESC	embryonic stem cell:	n/a	n/a
12	BCL3	chr19:41650213-41650690	A549	lung:	n/a	n/a
13	BCL3	chr19:41681514-41682747	A549	lung:	n/a	n/a
14	BCL3	chr19:41681572-41682628	A549	lung:	n/a	n/a
15	BHLHE40	chr19:41650351-41650568	K562	blood:	n/a	n/a
16	BHLHE40	chr19:41650454-41650612	GM12878	blood:	n/a	n/a
17	BHLHE40	chr19:41670430-41670548	K562	blood:	n/a	n/a
18	BRCA1	chr19:41664942-41665424	Hela-S3	cervix:	n/a	n/a
19	BRCA1	chr19:41672882-41672907	HepG2	liver:	n/a	n/a
20	CBX3	chr19:41633673-41634067	K562	blood:	n/a	n/a
21	CBX3	chr19:41650196-41650694	HCT-116	colon:	n/a	n/a
22	CBX3	chr19:41681739-41682618	HCT-116	colon:	n/a	n/a
23	CBX3	chr19:41641205-41641658	K562	blood:	n/a	n/a
24	CEBPB	chr19:41633758-41633806	A549	lung:	n/a	n/a
25	CEBPB	chr19:41665864-41666153	HepG2	liver:	n/a	n/a
26	CEBPB	chr19:41675306-41675391	K562	blood:	n/a	n/a
27	CEBPB	chr19:41652831-41653077	K562	blood:	n/a	n/a
28	CEBPB	chr19:41633738-41633817	Hela-S3	cervix:	n/a	n/a
29	CEBPB	chr19:41660715-41660891	Hela-S3	cervix:	n/a	n/a
30	CEBPB	chr19:41665826-41666210	K562	blood:	n/a	n/a
31	CEBPB	chr19:41665817-41666220	K562	blood:	n/a	n/a
32	CEBPB	chr19:41652881-41653002	IMR90	lung:	n/a	n/a
33	CEBPB	chr19:41646110-41646216	K562	blood:	n/a	n/a
34	CEBPB	chr19:41645981-41646375	Hela-S3	cervix:	n/a	n/a
35	CEBPB	chr19:41665850-41666174	HepG2	liver:	n/a	n/a
36	CEBPB	chr19:41665899-41666177	A549	lung:	n/a	n/a
37	CEBPB	chr19:41646052-41646323	A549	lung:	n/a	n/a
38	CEBPB	chr19:41641877-41641888	H1-hESC	embryonic stem cell:	n/a	n/a
39	CEBPB	chr19:41646152-41646259	HepG2	liver:	n/a	n/a
40	CEBPB	chr19:41665915-41666136	K562	blood:	n/a	n/a
41	CEBPB	chr19:41665820-41666265	Hela-S3	cervix:	n/a	n/a
42	CEBPB	chr19:41632768-41633061	H1-hESC	embryonic stem cell:	n/a	n/a
43	CEBPB	chr19:41669772-41669834	K562	blood:	n/a	n/a
44	CEBPB	chr19:41681962-41682433	Hela-S3	cervix:	n/a	n/a
45	CEBPB	chr19:41664961-41665438	Hela-S3	cervix:	n/a	n/a
46	CEBPB	chr19:41665004-41665316	HepG2	liver:	n/a	n/a
47	CEBPB	chr19:41652730-41653074	H1-hESC	embryonic stem cell:	n/a	n/a
48	CEBPD	chr19:41665807-41666287	K562	blood:	n/a	n/a
49	CEBPD	chr19:41665800-41666259	K562	blood:	n/a	n/a
50	CHD2	chr19:41681652-41682035	H1-hESC	embryonic stem cell:	n/a	n/a

(count:1038 , 50 per page) page: 1 2 3 4 5 6 7 ... 21

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr19:41642064-41642114	CMK	blood:	n/a
2	chr19:41642064-41642114	CMK	blood:	n/a
3	chr19:41641742-41641792	RPTEC	kidney:	n/a
4	chr19:41642394-41642444	NB4	blood:	n/a
5	chr19:41641434-41641484	Hela-S3	cervix:	n/a
6	chr19:41642064-41642114	HRPEpiC	eye:	n/a
7	chr19:41633906-41633956	ECC-1	luminal epithelium:	n/a
8	chr19:41633906-41633956	GM06990	blood:	n/a
9	chr19:41634046-41634096	ProgFib	skin:	n/a
10	chr19:41644902-41644952	SAEC	small airway:	n/a
11	chr19:41641742-41641792	GM12891	blood:	n/a
12	chr19:41637224-41637274	HUVEC	blood vessel:	n/a
13	chr19:41640397-41640447	NHDF-neo	bronchial:	n/a
14	chr19:41634046-41634096	GM19239	blood:	n/a
15	chr19:41634046-41634096	HRE	kidney:	n/a
16	chr19:41640676-41640726	PrEC	prostate:	n/a
17	chr19:41644902-41644952	BJ	skin:	n/a
18	chr19:41633902-41633952	HRCEpiC	kidney:	n/a
19	chr19:41637224-41637274	HPAEpiC	pulmonary alveolar:	n/a
20	chr19:41641742-41641792	GM12892	blood:	n/a
21	chr19:41632920-41632970	MCF-7	breast:	n/a
22	chr19:41639260-41639310	GM06990	blood:	n/a
23	chr19:41633902-41633952	HL-60	blood:	n/a
24	chr19:41632920-41632970	PANC-1	pancreas:	n/a
25	chr19:41640789-41640839	NH-A	brain:	n/a
26	chr19:41643199-41643249	Caco-2	colon:	n/a
27	chr19:41644902-41644952	NH-A	brain:	n/a
28	chr19:41633906-41633956	T-47D	breast:	n/a
29	chr19:41637224-41637274	GM19239	blood:	n/a
30	chr19:41633906-41633956	K562	blood:	n/a
31	chr19:41640676-41640726	HMEC	breast:	n/a
32	chr19:41643199-41643249	HRE	kidney:	n/a
33	chr19:41644902-41644952	NHBE	bronchial:	n/a
34	chr19:41633902-41633952	NH-A	brain:	n/a
35	chr19:41634046-41634096	IMR90	lung:	fetal
36	chr19:41633902-41633952	IMR90	lung:	fetal
37	chr19:41641742-41641792	SKMC	muscle:	n/a
38	chr19:41632920-41632970	HEK293	kidney:	embryo
39	chr19:41641847-41641897	PFSK-1	brain:	n/a
40	chr19:41641742-41641792	BE2_C	brain:	n/a
41	chr19:41644902-41644952	NHDF-neo	bronchial:	n/a
42	chr19:41633906-41633956	U87	brain:	n/a
43	chr19:41641434-41641484	HCM	heart:	n/a
44	chr19:41641434-41641484	NHDF-neo	bronchial:	n/a
45	chr19:41643199-41643249	HPAEpiC	pulmonary alveolar:	n/a
46	chr19:41644902-41644952	Caco-2	colon:	n/a
47	chr19:41633906-41633956	MCF-7	breast:	n/a
48	chr19:41634828-41634878	GM06990	blood:	n/a
49	chr19:41633902-41633952	Caco-2	colon:	n/a
50	chr19:41639260-41639310	HIPEpiC	eye:	n/a

(count:13 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr19:41664966..41667782-chr19:41768471..41770752,2	K562	blood:
2	chr19:41480596..41481177-chr19:41649752..41650983,4	K562	blood:
3	chr19:41678854..41681708-chr19:41768595..41770762,2	MCF-7	breast:
4	chr19:41633343..41635661-chr19:41766604..41769050,2	K562	blood:
5	chr19:41653070..41654935-chr19:41767041..41769003,2	MCF-7	breast:
6	chr19:41480412..41481100-chr19:41650028..41650578,2	MCF-7	breast:
7	chr19:41680953..41683356-chr19:41768146..41770884,2	MCF-7	breast:
8	chr19:41676947..41678469-chr19:41769052..41771501,2	MCF-7	breast:
9	chr19:41310257..41312648-chr19:41642254..41645069,2	K562	blood:
10	chr19:41660004..41661547-chr19:41766928..41769165,2	MCF-7	breast:
11	chr19:41631544..41633545-chr19:41769821..41772768,2	MCF-7	breast:
12	chr19:41323756..41325875-chr19:41632979..41635488,2	MCF-7	breast:
13	chr19:41168379..41168947-chr19:41650043..41650891,2	MCF-7	breast:

(count:1 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-CYP2A7P1-2	chr19:41642278-41642471	NONHSAT066433

No data

Variant related genes	Relation type
RPL36P16	TF binding region
CYP2T3P	TF binding region
RPL36P16	CpG island
CYP2T3P	CpG island
ENSG00000269858	chromatin interactions
ENSG00000105323	chromatin interactions

Extended variants
information (count: 2160 )
Associated
traits (count: 64 )

Variant overlapped rSNPs/rCNVs (count:2160 , 50 per page) page: 1 2 3 4 5 6 7 ... 44

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs59812390	chr19:41632758-41632759	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
2	rs112870838	chr19:41632779-41632780	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
3	rs570367199	chr19:41632797-41632798	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
4	rs528379396	chr19:41632801-41632802	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
5	rs59797778	chr19:41632805-41632806	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
6	rs182062302	chr19:41632827-41632828	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
7	rs368117314	chr19:41632862-41632863	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
8	rs556970445	chr19:41632891-41632892	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
9	rs73545069	chr19:41632980-41632981	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
10	rs539594808	chr19:41632999-41633000	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
11	rs189102388	chr19:41633003-41633004	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
12	rs305979	chr19:41633041-41633042	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
13	rs540432307	chr19:41633050-41633051	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
14	rs555673504	chr19:41633068-41633069	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
15	rs574002222	chr19:41633108-41633109	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
16	rs546920338	chr19:41633117-41633118	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
17	rs148864992	chr19:41633121-41633122	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
18	rs192106763	chr19:41633170-41633171	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
19	rs533045662	chr19:41633245-41633246	Enhancers Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
20	rs373196204	chr19:41633300-41633301	Enhancers Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
21	rs544735647	chr19:41633303-41633304	Enhancers Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
22	rs544773554	chr19:41633319-41633320	Enhancers Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
23	rs560194555	chr19:41633322-41633323	Enhancers Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
24	rs572428288	chr19:41633337-41633338	Enhancers Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
25	rs184047924	chr19:41633352-41633353	Enhancers Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
26	rs143563665	chr19:41633368-41633369	Enhancers Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
27	rs568397772	chr19:41633401-41633402	Weak transcription Enhancers Bivalent/Poised TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
28	rs188495656	chr19:41633411-41633412	Weak transcription Enhancers Bivalent/Poised TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
29	rs137919170	chr19:41633429-41633430	Weak transcription Enhancers Bivalent/Poised TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
30	rs569197765	chr19:41633452-41633453	Weak transcription Enhancers Bivalent/Poised TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
31	rs3901000	chr19:41633459-41633460	Weak transcription Enhancers Bivalent/Poised TSS	Chromatin interactive region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
32	rs533664277	chr19:41633497-41633498	Weak transcription Enhancers Bivalent/Poised TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
33	rs557919377	chr19:41633498-41633499	Weak transcription Enhancers Bivalent/Poised TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
34	rs566977696	chr19:41633513-41633514	Weak transcription Enhancers Bivalent/Poised TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
35	rs558252337	chr19:41633530-41633531	Weak transcription Enhancers Bivalent/Poised TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
36	rs144593218	chr19:41633531-41633532	Weak transcription Enhancers Bivalent/Poised TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
37	rs573962911	chr19:41633538-41633539	Weak transcription Enhancers Bivalent/Poised TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
38	rs138552052	chr19:41633546-41633547	Weak transcription Enhancers Bivalent/Poised TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
39	rs116844571	chr19:41633567-41633568	Weak transcription Enhancers Bivalent/Poised TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
40	rs577517958	chr19:41633568-41633569	Weak transcription Enhancers Bivalent/Poised TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
41	rs372345706	chr19:41633604-41633605	Enhancers Active TSS Weak transcription Flanking Active TSS Bivalent/Poised TSS Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
42	rs73545072	chr19:41633636-41633637	Enhancers Active TSS Weak transcription Flanking Active TSS Bivalent/Poised TSS Bivalent Enhancer	Chromatin interactive region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
43	rs529253614	chr19:41633642-41633643	Enhancers Active TSS Weak transcription Flanking Active TSS Bivalent/Poised TSS Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
44	rs386809336	chr19:41633669-41633670	Enhancers Active TSS Weak transcription Flanking Active TSS Bivalent/Poised TSS Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
45	rs150680592	chr19:41633670-41633671	Enhancers Active TSS Weak transcription Flanking Active TSS Bivalent/Poised TSS Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
46	rs140007678	chr19:41633677-41633678	Enhancers Active TSS Weak transcription Flanking Active TSS Bivalent/Poised TSS Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
47	rs192100365	chr19:41633699-41633700	Enhancers Active TSS Weak transcription Flanking Active TSS Bivalent/Poised TSS Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
48	rs369538837	chr19:41633703-41633704	Enhancers Active TSS Weak transcription Flanking Active TSS Bivalent/Poised TSS Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
49	rs149394322	chr19:41633715-41633716	Enhancers Active TSS Weak transcription Flanking Active TSS Bivalent/Poised TSS Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
50	rs550822719	chr19:41633718-41633719	Enhancers Active TSS Weak transcription Flanking Active TSS Bivalent/Poised TSS Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:64)

Disease	PMID	Source
Myelodysplastic syndrome	17634407	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Chordoma	21602918	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Cancer	21637783	CNVD
Retinoblastoma	21504564	CNVD
Medulloblastoma	21979893	CNVD
Ovarian cancer	21720365	CNVD
Cancer	20164919	CNVD
Thoracic aortic aneurysm	21092924	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Prostate cancer	18632612	CNVD
Autism	22495311	CNVD
Adenoid cystic carcinoma	18698036	CNVD
Ductal carcinoma	22052326	CNVD
Congenital nephrotic syndrome	18421352	CNVD
Astrocytoma	17934521	CNVD
Leukemia	17361228	CNVD
Adenoid cystic carcinoma	17372589	CNVD
Breast cancer	21858162	CNVD
Breast cancer	17603634	CNVD
Glioma	21971842	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Endometrial cancer	22040021	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Oligodendroglial tumors	17285580	CNVD
renal disease	20603712	CNVD
Salivary gland adenoid cystic carcinoma	17545515	CNVD
Ovarian cancer	22174824	CNVD
Breast cancer	16608533	CNVD
Neuroblastoma	18923191	CNVD
Breast cancer	21364760	CNVD
Invasive pancreatic ductal carcinoma	18765526	CNVD
Rhabdomyosarcoma	16790082	CNVD
Chordoma	18071362	CNVD
Urothelial carcinoma	21177765	CNVD
small cell lung cancer	20016488	CNVD
Wilms tumour	21544195	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Ovarian neoplasms	16753589	CNVD
Malignant fibrous histiocytomas	21085701	CNVD
Metanephric adenoma	20802469	CNVD
Acute myeloid leukemia	16864856	CNVD
Bladder cancer	21909424	CNVD
Medulloblastoma	16783165	CNVD
Gastric cancer	18160780	CNVD
Hepatocellular carcinoma	16750200	CNVD
Basal cell lymphoma	19029149	CNVD
Breast cancer	20409316	CNVD
Diffuse large b-cell lymphoma	19029149	CNVD
Multiple myeloma	16616336	CNVD
Renal cell carcinoma	18765545	CNVD
Acute myeloid leukemia	20729466	CNVD
Lung cancer	18438408	CNVD
Genital abnormality	22378287	CNVD
Hypospadia	22378287	CNVD
Ovarian clear cell carcinoma	19293255	CNVD
Astrocytoma	22246337	CNVD
early-passage human iPS cells	21368824	CNVD
Breast cancer	22522925	CNVD
Pancreatic cancer	17952125	CNVD

Chromatin state (count:890 , 50 per page) page: 1 2 3 4 5 6 7 ... 18

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr19:41627200-41633800	Weak transcription	Esophagus	oesophagus
2	chr19:41627200-41634000	Weak transcription	Pancreas	Pancrea
3	chr19:41627400-41632800	Weak transcription	Primary T helper naive cells fromperipheralblood	blood
4	chr19:41627400-41632800	Weak transcription	Primary T helper memory cells from peripheral blood 1	blood
5	chr19:41627400-41641600	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
6	chr19:41627600-41632800	Weak transcription	Primary T helper memory cells from peripheral blood 2	blood
7	chr19:41627600-41632800	Weak transcription	Primary T helper 17 cells PMA-I stimulated	--
8	chr19:41627600-41632800	Weak transcription	Primary T helper cells fromperipheralblood	blood
9	chr19:41627600-41633000	Weak transcription	Primary T regulatory cells fromperipheralblood	blood
10	chr19:41628000-41632800	Weak transcription	Primary T helper naive cells from peripheral blood	blood
11	chr19:41628000-41632800	Weak transcription	Primary T helper cells PMA-I stimulated	--
12	chr19:41628000-41632800	Weak transcription	Primary T killer memory cells from peripheral blood	blood
13	chr19:41628000-41633600	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Male	--
14	chr19:41628200-41633800	Weak transcription	Gastric	stomach
15	chr19:41629000-41632800	Weak transcription	Primary T killer naive cells fromperipheralblood	blood
16	chr19:41630200-41634000	Weak transcription	Primary hematopoietic stem cells short term culture	blood
17	chr19:41630800-41633200	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
18	chr19:41630800-41633600	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
19	chr19:41631000-41633600	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
20	chr19:41632400-41633800	Enhancers	Primary T cells fromperipheralblood	blood
21	chr19:41632400-41634800	Enhancers	Primary Natural Killer cells fromperipheralblood	blood
22	chr19:41632800-41633000	Enhancers	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
23	chr19:41632800-41633600	Enhancers	A549	lung
24	chr19:41632800-41633800	Enhancers	Primary T helper cells PMA-I stimulated	--
25	chr19:41632800-41634200	Enhancers	Liver	Liver
26	chr19:41632800-41634600	Enhancers	Primary T helper memory cells from peripheral blood 2	blood
27	chr19:41632800-41634800	Enhancers	Primary T helper naive cells fromperipheralblood	blood
28	chr19:41632800-41634800	Enhancers	Primary T helper memory cells from peripheral blood 1	blood
29	chr19:41632800-41634800	Enhancers	Primary T helper 17 cells PMA-I stimulated	--
30	chr19:41632800-41634800	Enhancers	Primary T helper cells fromperipheralblood	blood
31	chr19:41632800-41634800	Enhancers	Primary T cells effector/memory enriched fromperipheralblood	blood
32	chr19:41632800-41634800	Enhancers	Primary T killer naive cells fromperipheralblood	blood
33	chr19:41632800-41634800	Enhancers	Primary T killer memory cells from peripheral blood	blood
34	chr19:41632800-41634800	Enhancers	Placenta	Placenta
35	chr19:41632800-41635000	Enhancers	Primary T helper naive cells from peripheral blood	blood
36	chr19:41633000-41633800	Enhancers	Primary T regulatory cells fromperipheralblood	blood
37	chr19:41633200-41633400	Enhancers	H1 Cell Line	embryonic stem cell
38	chr19:41633200-41633400	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
39	chr19:41633400-41633600	Enhancers	iPS-20b Cell Line	embryonic stem cell
40	chr19:41633400-41633800	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
41	chr19:41633400-41633800	Enhancers	Duodenum Smooth Muscle	Duodenum
42	chr19:41633400-41634000	Enhancers	Duodenum Mucosa	Duodenum
43	chr19:41633400-41634200	Bivalent/Poised TSS	Foreskin Fibroblast Primary Cells skin02	Skin
44	chr19:41633400-41634400	Enhancers	Fetal Intestine Small	intestine
45	chr19:41633400-41634600	Enhancers	Primary B cells from peripheral blood	blood
46	chr19:41633400-41634600	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
47	chr19:41633400-41634600	Enhancers	Hela-S3	cervix
48	chr19:41633600-41633800	Enhancers	HUES6 Cell Line	embryonic stem cell
49	chr19:41633600-41633800	Enhancers	Primary T cells from cord blood	blood
50	chr19:41633600-41633800	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links